By Market News Video Staff, Friday, October 1, 8:43 AM ET
The PowerShares Global Biotech Portfolio (PBTQ) has a market value of only $3.7 million, but this tiny ETF is up nearly 17% over the last three months.
The underlying index is designed to measure the overall performance of globally traded securities of the largest and most liquid companies involved in the biotechnology industry.
Top holdings include Celgene (NASDAQ:CELG), up 13.4% over the last three months, Gilead Sciences (NASDAQ:GILD), higher by about 4% over the period, CSL, Amgen (NASDAQ:AMGN), higher by 4.75%, and Genzyme (NASDAQ:GENZ) up 39.5% over the three months.
This Article's Word Cloud:AMGNAmgenBiotechCELGCelgeneGENZGILDGenzymeGileadGlobalPBTQPortfolioPowerSharesSciencesaboutbiotechnologycompaniesdesignedgloballyhigherholdingsincludeindexindustryinvolvedlargestlastliquidmarketmeasuremillionmonthsmostnearlyonlyoveroverallperformanceperiodsecuritiesthisthreetinytradedunderlyingvalue
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.